Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
BEAT [NASD]
BioTelemetry, Inc.
Index- P/E- EPS (ttm)-0.42 Insider Own3.20% Shs Outstand26.46M Perf Week-0.27%
Market Cap192.36M Forward P/E49.12 EPS next Y0.15 Insider Trans13.24% Shs Float25.41M Perf Month3.12%
Income-11.00M PEG- EPS next Q0.02 Inst Own75.90% Short Float6.75% Perf Quarter6.75%
Sales144.80M P/S1.33 EPS this Y40.80% Inst Trans1.68% Short Ratio7.01 Perf Half Y-10.14%
Book/sh2.37 P/B3.07 EPS next Y146.67% ROA-11.00% Target Price14.00 Perf Year-25.89%
Cash/sh0.51 P/C14.25 EPS next 5Y- ROE-17.10% 52W Range6.42 - 11.98 Perf YTD-8.44%
Dividend- P/FCF- EPS past 5Y-24.60% ROI-10.50% 52W High-39.32% Beta1.24
Dividend %- Quick Ratio1.10 Sales past 5Y1.50% Gross Margin58.90% 52W Low13.24% ATR0.29
Employees622 Current Ratio1.20 Sales Q/Q-33.80% Oper. Margin0.70% RSI (14)55.45 Volatility2.90% 4.38%
OptionableYes Debt/Eq0.30 EPS Q/Q11.80% Profit Margin-7.70% Rel Volume0.42 Prev Close7.22
ShortableYes LT Debt/Eq0.28 EarningsNov 03 Payout- Avg Volume244.73K Price7.27
Recom2.00 SMA205.19% SMA503.30% SMA200-8.48% Volume103,760 Change0.69%
24-Oct-13Initiated The Benchmark Company Buy $15
21-Aug-13Initiated Dougherty & Company Buy
06-May-11Reiterated Barrington Research Outperform $9 → $7
28-Jun-10Reiterated Brean Murray Buy $15 → $10
03-May-10Reiterated Barrington Research Outperform $9 → $12
29-Apr-10Reiterated Brean Murray Buy $9 → $15
06-Apr-10Upgrade Roth Capital Hold → Buy $7 → $12
10-Mar-10Upgrade Jefferies & Co Underperform → Hold $4 → $7
18-Feb-10Upgrade Brean Murray Hold → Buy $9
08-Jan-10Initiated Barrington Research Outperform $9
16-Dec-09Upgrade Leerink Swann Mkt Perform → Outperform
09-Nov-09Downgrade Brean Murray Buy → Hold
01-Oct-09Initiated William Blair Mkt Perform
06-Aug-09Upgrade Brean Murray Hold → Buy $7
13-Jul-09Reiterated Jefferies & Co Underperform $17 → $5
13-Jul-09Downgrade Leerink Swann Outperform → Mkt Perform
13-Jul-09Downgrade Boenning & Scattergood Outperform → Neutral
01-Jul-09Downgrade Roth Capital Buy → Hold $29 → $18
01-Jul-09Downgrade Citigroup Buy → Hold
30-Jun-09Initiated Boenning & Scattergood Outperform $25
22-Oct-14 04:30PM  BioTelemetry, Inc. to Release Third Quarter 2014 Earnings Results on October 30, 2014 GlobeNewswire
16-Oct-14 04:05PM  BioTelemetry, Inc. Announces Reinstatement of Cigna Corporation's Coverage of Mobile Cardiac Monitoring Services GlobeNewswire
13-Aug-14 10:00AM  BioTelemetry, Inc. (NASDAQ: BEAT) to Ring The NASDAQ Stock Market Opening Bell GlobeNewswire
08-Aug-14 01:04PM  BIOTELEMETRY, INC. Financials EDGAR Online Financials
01-Aug-14 12:00PM  BIOTELEMETRY, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
31-Jul-14 05:00PM  BioTelemetry Inc Earnings Call scheduled for 5:00 pm ET today CCBN
04:31PM  BIOTELEMETRY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
04:05PM  BioTelemetry, Inc. Reports Second Quarter 2014 Financial Results GlobeNewswire
07:07AM  Q2 2014 BioTelemetry Inc Earnings Release - 4:00 pm ET CCBN
22-Jul-14 01:15PM  BioTelemetry, Inc. to Release Second Quarter 2014 Earnings Results on July 31, 2014 GlobeNewswire
11-Jun-14 06:30AM  3 Stocks Under $10 Making Big Moves at TheStreet
05-Jun-14 12:21PM  BioTelemetry unit acquires assets of RadCore Lab at theflyonthewall.com
12:19PM  BioTelemetry, Inc. Announces Major Advancements in Research Services GlobeNewswire
03-Jun-14 11:12AM  BioTelemetry Inc Stock Downgraded (BEAT) at TheStreet
08-May-14 02:30PM  Covance Posts In-line Q1 Earnings; Falls on Trimmed View Zacks
07-May-14 09:33AM  BIOTELEMETRY, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online -20.79%
07:03AM  How BioTelemetry (BEAT) Stock Stands Out in a Strong Industry Zacks
06-May-14 09:01PM  BioTelemetry 's (BEAT) CEO Joseph Capper on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
05:00PM  BioTelemetry, Inc. Earnings Call scheduled for 5:00 pm ET today CCBN
04:31PM  BIOTELEMETRY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
04:05PM  BioTelemetry, Inc. Reports First Quarter 2014 Financial Results GlobeNewswire
07:07AM  Q1 2014 BioTelemetry, Inc. Earnings Release - Time Not Supplied CCBN
02-May-14 06:43AM  Weakness Seen in The Spectranetics Corporation (SPNC) Estimates: Should You Stay Away? Zacks
30-Apr-14 10:52AM  BioTelemetry, Inc. to Release First Quarter 2014 Earnings Results on May 6, 2014 GlobeNewswire
04-Apr-14 06:02AM  BIOTELEMETRY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Dispo EDGAR Online -7.71%
20-Mar-14 08:05AM  BioTelemetry, Inc. Announces the Acquisition of the Cardiac Patient Services Business of Biomedical Systems, Corp. GlobeNewswire +7.75%
08:01AM  BIOTELEMETRY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
11-Mar-14 07:01AM  BioTelemetry (BEAT): Strong Industry, Solid Earnings Estimate Revisions Zacks
08-Mar-14 01:04PM  BIOTELEMETRY, INC. Financials EDGAR Online Financials
06-Mar-14 06:00AM  Why BioTelemetry (BEAT) Could Be Positioned for a Surge? Zacks -5.04%
28-Feb-14 03:06AM  BioTelemetry, Inc. (BEAT) Surges: Stock Moves 13.6% Higher Zacks
27-Feb-14 01:52PM  Why BioTelemetry (BEAT) Is Spiking Today at TheStreet +13.60%
09:10AM  Morning Movers: JC Penney Skyrockets on Earnings; Noodles Drops on Miss at Barrons.com
05:56AM  Surging Rank, Surging Stock: Why BioTelemetry (BEAT) Is a Winner? Zacks
26-Feb-14 11:47PM  BioTelemetry's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
07:10PM  On The Fly: After Hours Movers at theflyonthewall.com
05:00PM  BioTelemetry, Inc. Earnings Call scheduled for 5:00 pm ET today CCBN
04:55PM  BioTelemetry, Inc. Discusses Q4 2013 Results (Webcast) at Seeking Alpha
04:31PM  BIOTELEMETRY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
04:05PM  BioTelemetry, Inc. Reports Fourth Quarter and Full Year 2013 Financial Results GlobeNewswire
07:07AM  Q4 2013 BioTelemetry, Inc. Earnings Release - After Market Close CCBN
25-Feb-14 06:01AM  BIOTELEMETRY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obl EDGAR Online
20-Feb-14 11:30AM  Omnicare Earnings Rise but Miss Estimates Zacks
08:51AM  BioTelemetry (BEAT) Shares March Higher, Can It Continue? Zacks
05:53AM  Why Quintiles Transnational (Q) Has A Bright Short-Term Future? Zacks
18-Feb-14 04:16PM  BIOTELEMETRY, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online +6.11%
01:07PM  Healthways Sees 4Q Loss on Lower Revs Zacks
13-Feb-14 07:26PM  BioTelemetry, Inc. to Release Fourth Quarter 2013 Earnings Results on February 26, 2014 GlobeNewswire
04-Feb-14 06:59AM  BioTelemetry (BEAT) Soars: Stock Up 22.0% Zacks
03-Feb-14 05:16PM  Why BioTelemetry, Globalstar, and ArthroCare Are Today's 3 Best Stocks at Motley Fool +22.09%
04:17PM  BioTelemetry prevails in court, acquires rival AP
01:47PM  Why BioTelemetry (BEAT) Is Soaring Today at TheStreet
08:01AM  BIOTELEMETRY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obl EDGAR Online
08:00AM  BioTelemetry, Inc. Announces Significant Patent Litigation Victory and the Acquisition of Mednet Healthcare Technologies, Inc. GlobeNewswire
06-Jan-14 08:00AM  BioTelemetry, Inc. and Wellbridge Health, Inc. Announce Strategic Alliance GlobeNewswire
12-Dec-13 08:00AM  BioTelemetry, Inc. Announces Newly Published Research Demonstrating Significant Cost Savings With Use of Mobile Cardiac Telemetry GlobeNewswire -7.03%
11-Dec-13 06:21PM  Nasdaq stocks posting largest percentage increases AP +8.63%
04-Dec-13 02:53PM  InPlay: BioTelemetry announces reduction to Medicare reimbursement for remote cardiac monitoring services; will result in a 13.7% decrease to the national reimbursement rate for the MCOTTM service Briefing.com -19.94%
02:50PM  BioTelemetry, Inc. Announces Reduction to Medicare Reimbursement for Remote Cardiac Monitoring Services GlobeNewswire
01:11PM  BioTelemetry likely to see reduced Medicare revenue, says Lake Street at theflyonthewall.com
12:51PM  BioTelemetry weakness attributed to proposed CMS rate cut at theflyonthewall.com
11-Nov-13 08:17AM  Will BioTelemetry Inc. (BEAT) Continue to Surge Higher? Zacks
07-Nov-13 08:41AM  4 Unusual-Volume Stocks in Breakout Territory at TheStreet
05-Nov-13 05:00PM  CardioNet, Inc. Earnings Call scheduled for 5:00 pm ET today CCBN
04:55PM  BioTelemetry, Inc. Discusses Q3 2013 Results (Webcast) at Seeking Alpha
04:05PM  BioTelemetry, Inc. Reports Third Quarter 2013 Financial Results GlobeNewswire
07:07AM  Q3 2013 CardioNet, Inc. Earnings Release - 4:00 pm ET CCBN
BioTelemetry, Inc. provides cardiac monitoring, cardiac monitoring device manufacturing, and cardiac core laboratory services. It operates in three segments: Patient Services, Product, and Research Services. The Patient Services segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. This segment offers Mobile Cardiac Outpatient Telemetry service, which incorporates a lightweight patient-worn sensor attached to electrodes that capture two-channel electrocardiography (ECG) data, measuring electrical activity of the heart, on a compact wireless handheld monitor; event monitoring services to prescribe wireless event monitors, digital loop event monitors, memory loop event monitors, and non-loop event monitors; and a Holter monitor to cardiologists and electrophysiologists. The Product segment focuses on the manufacture, engineering, and development of noninvasive cardiac monitors for healthcare companies, clinics, and hospitals worldwide. This segment offers various devices, including cardiac event monitors, digital Holter monitors, and mobile cardiac telemetry monitors; and contract engineering and manufacturing services. The Research Services segment provides cardiac monitoring, scientific consulting, and data management services for drug and medical treatment trials to pharmaceutical companies, medical device companies, and contract research and academic research organizations. Its centralized services include ECG, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, protocol development, and expert reporting and statistical analysis. This segment also offers research services, such as project coordination, setup and management, equipment rental, data transfer, processing, and analysis, as well as 24/7 customer support and site training. The company is headquartered in Malvern, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AHRENS RONALD ADirectorMay 09Buy7.376,00044,220187,629May 13 05:15 PM
GORMAN KIRK EDirectorMay 09Buy7.316,50047,515166,437May 13 03:52 PM